APA (7th ed.) Citation

Baldi, G. G., Giani, C., Ljevar, S., Denu, R. A., Napolitano, A., Han, I., . . . Marquina, G. (2026). Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium. European Journal of Cancer, 238, N.PAG. https://doi.org/10.1016/j.ejca.2026.116666

Chicago Style (17th ed.) Citation

Baldi, Giacomo G., et al. "Pleomorphic Rhabdomyosarcoma, Outcomes of Patients with Advanced Disease Treated with Systemic Agents: Retrospective Study from the Global Pushing Ultra-rare Sarcomas Towards Hope (PUSH) Consortium." European Journal of Cancer 238 (2026): N.PAG. https://doi.org/10.1016/j.ejca.2026.116666.

MLA (9th ed.) Citation

Baldi, Giacomo G., et al. "Pleomorphic Rhabdomyosarcoma, Outcomes of Patients with Advanced Disease Treated with Systemic Agents: Retrospective Study from the Global Pushing Ultra-rare Sarcomas Towards Hope (PUSH) Consortium." European Journal of Cancer, vol. 238, 2026, p. N.PAG, https://doi.org/10.1016/j.ejca.2026.116666.